Follow the people · Insider
Brett P. Monia
Brett P. Monia files insider transactions with the SEC as a chief executive officer of Ionis Pharmaceuticals (IONS). We hold 10 disclosed purchases and sales filed since 3 January 2012, 3 of them in the last 90 days.
- Files forIONS
- Disclosed buys and sells10 in all, 3 in the last 90 days
- Last disclosure2 September 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 January 2016 — 31 August 2026Chief Executive Officer · Ionis Pharmaceuticals (IONS)234 Form 4 lines · source: SEC Form 4
- Filed 10 June 2022 — 17 June 2026Director · Cognition Therapeutics (CGTX)8 Form 4 lines · source: SEC Form 4
- Filed 23 November 2018 — 23 November 2018Chief Operating Officer · Ionis Pharmaceuticals (IONIS)3 Form 4 lines · source: SEC Form 4
- Filed 1 January 2012 — 2 July 2015SVP, Antisense Drug Discovery · Isis Pharmaceuticals (ISIS)98 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- acquired or disposed of, other 98 shares of Ionis PharmaceuticalsSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- exercised options over 14,565 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- ▼ sold on the open market 14,565 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 24 June 2026 · filed 26 June 2026
- exercised options over 21,072 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 25 June 2026 · filed 26 June 2026
- ▼ sold on the open market 21,072 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 25 June 2026 · filed 26 June 2026
- exercised options over 50,000 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 50,000 shares of Ionis PharmaceuticalsSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- exercised options over 14,565 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 426 June 2026Non-Qualified Stock Option (right to buy) · traded 24 June 2026 · filed 26 June 2026
- exercised options over 21,072 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 426 June 2026Non-Qualified Stock Option (right to buy) · traded 25 June 2026 · filed 26 June 2026
- exercised options over 50,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 426 June 2026Non-Qualified Stock Option (right to buy) · traded 26 June 2026 · filed 26 June 2026
- was granted 25,000 shares of Cognition TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- exercised options over 1,316 shares of Ionis PharmaceuticalsSEC Form 415 May 2026Common Stock · traded 13 May 2026 · filed 15 May 2026
- ▼ sold on the open market 1,316 shares of Ionis PharmaceuticalsSEC Form 415 May 2026Common Stock · traded 13 May 2026 · filed 15 May 2026
- exercised options over 3,220 shares of Ionis PharmaceuticalsSEC Form 415 May 2026Common Stock · traded 14 May 2026 · filed 15 May 2026
- ▼ sold on the open market 3,220 shares of Ionis PharmaceuticalsSEC Form 415 May 2026Common Stock · traded 14 May 2026 · filed 15 May 2026
- exercised options over 1,316 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 415 May 2026Non-Qualified Stock Option (right to buy) · traded 13 May 2026 · filed 15 May 2026
- exercised options over 3,220 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 415 May 2026Non-Qualified Stock Option (right to buy) · traded 14 May 2026 · filed 15 May 2026
- exercised options over 40,822 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 73,529 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- exercised options over 34,103 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 10 March 2026 · filed 11 March 2026
- exercised options over 73,529 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 7,382 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 40,822 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- exercised options over 73,529 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- exercised options over 34,103 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 117,604 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 1,684 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 34,103 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 16,512 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 17,591 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- exercised options over 40,822 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 73,529 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 7,382 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 117,604 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 1,684 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- exercised options over 34,103 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 16,512 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 17,591 shares of Ionis PharmaceuticalsSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- exercised options over 40,822 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 411 March 2026Non-Qualified Stock Option (right to buy) · traded 9 March 2026 · filed 11 March 2026
- acquired or disposed of, other 484 shares of Ionis PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- acquired or disposed of, other 484 shares of Ionis PharmaceuticalsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 29,430 shares of Ionis PharmaceuticalsSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- ▼ sold on the open market 29,430 shares of Ionis PharmaceuticalsSEC Form 410 February 2026Common Stock · traded 6 February 2026 · filed 10 February 2026
- was granted 122,214 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 62,970 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- was granted 122,214 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 62,970 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- exercised options over 89,145 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 44,034 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- was granted 113,880 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Performance Restricted Stock Units · traded 15 January 2026 · filed 20 January 2026
- was granted 113,880 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Performance Restricted Stock Units · traded 15 January 2026 · filed 20 January 2026
- exercised options over 89,145 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 42,705 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 89,145 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 42,705 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 89,145 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 44,034 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- was granted 85,410 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 85,410 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 437 shares of Ionis PharmaceuticalsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- exercised options over 31,316 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Non-Qualified Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- exercised options over 27,568 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Non-Qualified Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- exercised options over 42,030 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Non-Qualified Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- exercised options over 102,900 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Non-Qualified Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- exercised options over 102,900 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 16,615 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- exercised options over 42,030 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 127,500 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- exercised options over 31,316 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- exercised options over 27,568 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 59,699 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- acquired or disposed of, other 189 shares of Ionis PharmaceuticalsSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
- exercised options over 2,432 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 41 August 2025Non-Qualified Stock Option (right to buy) · traded 30 July 2025 · filed 1 August 2025
- exercised options over 2,432 shares of Ionis PharmaceuticalsSEC Form 41 August 2025Common Stock · traded 30 July 2025 · filed 1 August 2025
- ▼ sold on the open market 2,432 shares of Ionis PharmaceuticalsSEC Form 41 August 2025Common Stock · traded 30 July 2025 · filed 1 August 2025
- ▼ sold on the open market 1,160 shares of Ionis PharmaceuticalsSEC Form 415 July 2025Common Stock · traded 11 July 2025 · filed 15 July 2025
- was granted 34,000 shares of Cognition TherapeuticsSEC Form 423 June 2025Common Stock · traded 18 June 2025 · filed 23 June 2025
- ▼ sold on the open market 140 shares of Ionis PharmaceuticalsSEC Form 413 March 2025Common Stock · traded 11 March 2025 · filed 13 March 2025
- acquired or disposed of, other 437 shares of Ionis PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- ▼ sold on the open market 38,843 shares of Ionis PharmaceuticalsSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- was granted 25,372 shares of Ionis PharmaceuticalsSEC Form 43 February 2025Common Stock · traded 30 January 2025 · filed 3 February 2025
- ▼ sold on the open market 13,242 shares of Ionis PharmaceuticalsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- was granted 169,950 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Performance Restricted Stock Units · traded 15 January 2025 · filed 17 January 2025
- was granted 129,395 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Restricted Stock Unit · traded 15 January 2025 · filed 17 January 2025
- exercised options over 73,448 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Restricted Stock Unit · traded 15 January 2025 · filed 17 January 2025
- exercised options over 73,448 shares of Ionis PharmaceuticalsSEC Form 417 January 2025Common Stock · traded 15 January 2025 · filed 17 January 2025
- ▼ sold on the open market 33,445 shares of Ionis PharmaceuticalsSEC Form 417 January 2025Common Stock · traded 16 January 2025 · filed 17 January 2025
- was granted 86,263 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2025Non-Qualified Stock Option (right to buy) · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 6,630 shares of Ionis PharmaceuticalsSEC Form 414 November 2024Common Stock · traded 12 November 2024 · filed 14 November 2024
- ▼ sold on the open market 23,907 shares of Ionis PharmaceuticalsSEC Form 44 September 2024Common Stock · traded 2 February 2024 · filed 4 September 2024
- ▼ sold on the open market 23,907 shares of Ionis PharmaceuticalsSEC Form 44 September 2024Common Stock · traded 2 February 2024 · filed 4 September 2024
- acquired or disposed of, other 140 shares of Ionis PharmaceuticalsSEC Form 44 September 2024Common Stock · traded 30 August 2024 · filed 4 September 2024
- was granted 8,500 shares of Cognition Therapeutics (a derivative holding)SEC Form 411 June 2024Stock Option (right to buy) · traded 7 June 2024 · filed 11 June 2024
- was granted 8,500 shares of Cognition TherapeuticsSEC Form 411 June 2024Common Stock · traded 7 June 2024 · filed 11 June 2024
- acquired or disposed of, other 538 shares of Ionis PharmaceuticalsSEC Form 44 March 2024Common Stock · traded 29 February 2024 · filed 4 March 2024
- ▼ sold on the open market 387 shares of Ionis PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 16 February 2024 · filed 16 February 2024
- was granted 25,372 shares of Ionis PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 1 February 2024 · filed 2 February 2024
- was granted 20,416 shares of Ionis PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 1 February 2024 · filed 2 February 2024
- ▼ sold on the open market 23,501 shares of Ionis PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 2 February 2024 · filed 2 February 2024
- ▼ sold on the open market 2,285 shares of Ionis PharmaceuticalsSEC Form 429 January 2024Common Stock · traded 25 January 2024 · filed 29 January 2024
- exercised options over 68,084 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 January 2024Restricted Stock Unit · traded 16 January 2024 · filed 18 January 2024
- exercised options over 68,084 shares of Ionis PharmaceuticalsSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- ▼ sold on the open market 32,059 shares of Ionis PharmaceuticalsSEC Form 418 January 2024Common Stock · traded 17 January 2024 · filed 18 January 2024
- was granted 143,550 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2024Performance Restricted Stock Units · traded 15 January 2024 · filed 17 January 2024
- was granted 87,435 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2024Restricted Stock Unit · traded 15 January 2024 · filed 17 January 2024
- was granted 116,580 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 January 2024Non-Qualified Stock Option (right to buy) · traded 2 January 2024 · filed 4 January 2024
- exercised options over 6,500 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 422 December 2023Non-Qualified Stock Option (right to buy) · traded 20 December 2023 · filed 22 December 2023
- exercised options over 17,500 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 422 December 2023Non-Qualified Stock Option (right to buy) · traded 21 December 2023 · filed 22 December 2023
- exercised options over 6,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- ▼ sold on the open market 6,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- exercised options over 17,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 21 December 2023 · filed 22 December 2023
- ▼ sold on the open market 17,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 21 December 2023 · filed 22 December 2023
- exercised options over 14,860 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 December 2023Non-Qualified Stock Option (right to buy) · traded 14 December 2023 · filed 18 December 2023
- exercised options over 9,140 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 December 2023Non-Qualified Stock Option (right to buy) · traded 14 December 2023 · filed 18 December 2023
- exercised options over 14,860 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 14,860 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- exercised options over 9,140 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 9,140 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 3,770 shares of Ionis PharmaceuticalsSEC Form 416 October 2023Common Stock · traded 12 October 2023 · filed 16 October 2023
- acquired or disposed of, other 157 shares of Ionis PharmaceuticalsSEC Form 45 September 2023Common Stock · traded 31 August 2023 · filed 5 September 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.